Results 161 to 170 of about 18,841,230 (238)

DECIDER-2: Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapy. [PDF]

open access: yesBMC Cancer
Grishina O   +35 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy